🔥 Wednesday 21 October 2026 Wed, 21 Oct 2026

Kantra Copper delivered a fifth consecutive quarter of higher copper production, with net group cash flow rising 72% to $14.2 million and cash reaching $44.1 million. The ASX-listed miner also began Emily Star development and moved its Coburn project closer to a pre-feasibility study.

Maronan Metals has completed more than 15,000 metres of a 40,000-metre infill program and is preparing to accelerate work at its Queensland project with a proposed A$20 million placement. The funding remains subject to shareholder approval, while a new chief executive is due to take charge in November.

Genetic Signatures and Microba Life Sciences have agreed in principle to revise their proposed merger, reducing Microba shareholders’ post-deal ownership from about 67% to 60%. The change improves the position of existing GSS shareholders, but the transaction remains non-binding and subject to multiple approvals.

Service Stream has reported higher margins, earnings and dividends for FY26, while its newly mobilised Defence operations are positioned to contribute more meaningfully in FY27. The company enters the new year with $8.2 billion of work in hand, a net cash balance sheet and a positive but non-specific growth outlook.

Woodside delivered a stronger third quarter as production rose 12% and operating revenue reached US$4.281 billion. Scarborough is now 99% complete and remains on track for its first LNG cargo in Q4, while the company moves to reduce its Beaumont New Ammonia investment.

Cleo Diagnostics’ prototype ovarian cancer screening test met or exceeded every predefined performance target in a 247-person proof-of-concept study, including among 62 Stage I cases. The result moves the program into larger bridging and expanded studies, but it remains retrospective evidence rather than a validated screening test.

Findi says it has not secured financing or restructuring terms acceptable to the relevant parties, while its cash runway remains short and its ASX suspension continues. The company cannot provide a date for lodging its FY2026 audited accounts or Annual Report.

Trek Metals has confirmed a shallow, high-grade manganese discovery at Kuro in Western Australia, with 38 of 72 Phase 1 holes returning significant intercepts. Follow-up drilling is complete, while the company has also secured an option over a second manganese project in Arizona.

BLS Pharmaceuticals has started FY27 with its strongest quarter on record, reporting A$26.7 million in unaudited revenue and positive operating cash flow. The company reaffirmed its A$105 million to A$115 million revenue guidance while continuing to invest in Australian and Scottish manufacturing capacity.

Invion has secured two financing arrangements that could cover up to approximately 85% of its clinical trial costs, providing support for its skin cancer and planned anogenital cancer programs. The funding comes with potential dilution, 16% interest and conditions that leave the actual amount available dependent on drawdowns and R&D tax refunds.

SEEK has reset the economics of its Growth Fund’s second five-year phase, targeting at least $840 million in investor liquidity and approximately $700 million for itself. The plan reduces fees, separates core from non-core assets and ends further capital contributions from SEEK, but distributions remain dependent on asset sales and market conditions.

Telix reported US$245 million in unaudited third-quarter revenue, with Precision Medicine sales up 30% and full-year revenue and other income still expected to exceed US$1 billion. The quarter also advanced the proposed US$1.65 billion ITM merger, added FDA-approved Pixclara to the commercial portfolio and narrowed the R&D spending range.

Silver Mines has begun its first modern drilling program at the Kramer Hills gold project in California, targeting shallow oxide mineralisation and possible deeper sulphide zones. The 22-hole campaign will test a conceptual exploration target of up to 445,000 ounces, but the project remains well short of a JORC Mineral Resource.

Sigma Healthcare has entered FY27 with double-digit Chemist Warehouse sales growth, stronger earnings and a merger integration program targeting $100 million in annual synergies by FY29. The next test is whether store expansion and technology consolidation can convert momentum into durable cash returns.

Beach Energy delivered its strongest quarterly revenue result on record, with sales rising 41% to A$565 million as production increased 9% to 5.4 MMboe. Waitsia reliability improved, offshore abandonment work was completed and FY27 guidance remained unchanged.

CurveBeam AI has secured its strongest first-quarter HiRise sales result, gained China regulatory clearance and raised A$7.35 million to fund the next stage of commercialisation. The progress comes alongside lower customer receipts and a reported 4.3 quarters of cash runway.

Atlas Arteria’s proportional toll revenue fell 0.4% in the September quarter excluding foreign exchange, while a proposed French tax package could have added about €210 million to APRR Group costs under 2025 conditions. Stronger US and German traffic provided some offset, but the company remains exposed to weak French light-vehicle demand and uncertain legislation.

PLS has priced US$700 million of senior unsecured notes at an 8.00% coupon, adding a substantial source of funding as the lithium producer prepares for further capital investment. The notes mature in 2032, with settlement expected on 23 October subject to customary conditions.

GBM Resources has recorded rougher flotation recoveries of 92% to 99% from composite samples at its Twin Hills Gold Project in Queensland. The early results strengthen the case for conventional processing, although weaker 309 CIL recoveries mean the project’s final flowsheet remains unresolved.

FMR Resources has completed planning for at least 2,000 metres of drilling at La Lorena and identified five new intrusive targets in an eastern structural corridor. The Chile-focused explorer also exercised its Los Warbos option after quarter end, but reported cash of A$3.786 million and an estimated 2.51 quarters of funding at the September quarter’s spending rate.

PC Gold has reported a run of thick, stacked gold intercepts at its 1.51Moz Spring Hill project, with five of eight diamond holes delivering best single intercepts of about 70 gram-metres or more. The results add momentum ahead of a targeted December Mineral Resource Estimate update, while coarse-gold sampling and pending assays remain important variables.

Encounter Resources has extended a shallow, high-grade niobium zone at Joyce across more than 400 metres of strike, bringing a maiden resource estimate into view. The company has also identified copper anomalism in the southern part of the prospect, although that result remains early-stage.

Kingfisher Mining has reported strong September-quarter drilling results across its Broken Hill portfolio and secured approximately $2.25 million for further exploration. The next test is whether follow-up drilling can turn high-grade intersections into a larger, coherent mineralised system.

BPH Energy’s latest quarter puts its portfolio risks in sharp relief: Advent is appealing the PEP11 ruling while another subsidiary remains in voluntary administration. BPH ended September with $1.127 million in cash, but deployed $972,000 in loans to investees during the quarter.